ArticlePNAS nexus2025
Reversible formation of von-Willebrand-factor-platelet aggregates in microvascular blood flow.
Article in PNAS nexus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.Current opinion in hematology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Von Willebrand factor (VWF) and blood platelets play a key role in blood clotting by forming VWF-platelet aggregates. Using mesoscale hydrodynamic simulations, we study the behavior of these aggregates in microvascular blood flow. In microvessels, free VWF molecules and platelets migrate (or marginate) toward the vessel wall, due to the interaction with red blood cells under flow, such that their local concentration near the wall is substantially increased. Then, large shear rates near the wall facilitate the formation and growth of VWF-platelet aggregates. After reaching a certain size, the aggregates experience a hydrodynamic lift force and move away from the wall into the bulk flow, where local shear rates are relatively small, and dissociate reversibly into single components. Consequently, the described process repeats. In addition to the demonstration of recurrent formation and dissociation of VWF-platelet aggregates, our simulations show that shear activation of VWF and the interactions between VWF and platelets are the main determinants of this process. A significant change in the VWF shear activation or VWF-platelet interactions may readily lead to no aggregate formation or to the formation of irreversible aggregates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.